icon
0%

Borgwarner BWA - News Analyzed: 8,642 - Last Week: 100 - Last Month: 400

⇑ BorgWarner (BWA): A Robust Bio-tech Performer Fostering Investor Confidence

BorgWarner (BWA): A Robust Bio-tech Performer Fostering Investor Confidence

The numerous reports capture BorgWarner's (BWA) robust standing in the auto industry. BorgWarner maintained a 'Hold (C)' Rating at Weiss Ratings while expectations are high for earnings growth. Various financial firms have taken significant positions in BorgWarner, pointing at investor confidence. This includes large-scale share purchases like those by Principle Wealth Partners, FSM Wealth Advisors, Sequoia Financial Advisors, and Chicago Partners Investment Group. Despite some sales of shares, the company's valuation has largely remained steady. JP Morgan maintains an 'Overweight' stance on BWA, endorses a new price target of $53.00, also by JPMorgan Chase. Further, BorgWarner's ongoing commitment to hybrid vehicle strength earned a Baird upgrade to 'Outperform'. BorgWarner's upcoming dividend is expected to be larger than the previous year's. The company also reported Q2 earnings that beat estimates and announced a 55% increase in its quarterly dividend. BorgWarner also issued its sustainability report showing major progress

.

Borgwarner BWA News Analytics from Thu, 06 Feb 2025 08:00:00 GMT to Sun, 26 Oct 2025 00:49:54 GMT - Rating 8 - Innovation 3 - Rumor -7

The email address you have entered is invalid.